• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素受体与 miR-375 的甲基化介导的转录抑制在人前列腺癌细胞中呈负相关。

Androgen receptor is negatively correlated with the methylation-mediated transcriptional repression of miR-375 in human prostate cancer cells.

机构信息

State Key Laboratory of Oncogenes and Related Genes, Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China.

出版信息

Oncol Rep. 2014 Jan;31(1):34-40. doi: 10.3892/or.2013.2810. Epub 2013 Oct 24.

DOI:10.3892/or.2013.2810
PMID:24173286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3868498/
Abstract

Androgen receptor (AR) plays a critical role during the development and progression of prostate cancer in which microRNA miR-375 is overexpressed and correlated with tumor progression. Although DNA methylation is a key mechanism for the repression of gene expression, the relationship between AR and the expression or the hypermethylation of miR-375 is unknown. In this study, we found that AR-positive prostate cancer (PCa) cells showed high expression levels and hypomethylation of the miR-375. In contrast, AR-negative PCa cells displayed low levels and hypermethylation of the miR-375. Addition of 5-Aza-2'-deoxycytidine, a specific inhibitor of DNA methylation, into the culture medium reversed the low expression levels of miR-375 in the AR negative PCa cells. In addition, the total activity levels of DNA methyltransferases (DNMTs) were high in AR-negative PCa cells, in which hypermethylation of miR-375 promoter and low expression levels of miR-375 were observed. Taken together, these findings indicate that the negative correlation between AR and total DNMT activity is one of mechanisms to influence the methylation status of miR-375 promoter, which in turn regulates the expression of miR-375.

摘要

雄激素受体 (AR) 在前列腺癌的发展和进展中起着关键作用,其中 microRNA miR-375 过表达并与肿瘤进展相关。尽管 DNA 甲基化是抑制基因表达的关键机制,但 AR 与 miR-375 的表达或高甲基化之间的关系尚不清楚。在这项研究中,我们发现 AR 阳性前列腺癌 (PCa) 细胞表现出 miR-375 的高表达水平和低甲基化。相比之下,AR 阴性 PCa 细胞显示出 miR-375 的低水平和高甲基化。在培养基中添加 5-Aza-2'-脱氧胞苷,一种 DNA 甲基化的特异性抑制剂,可逆转 AR 阴性 PCa 细胞中 miR-375 的低表达水平。此外,AR 阴性 PCa 细胞中的总 DNA 甲基转移酶 (DNMT) 活性水平较高,观察到 miR-375 启动子的高甲基化和 miR-375 的低表达水平。综上所述,这些发现表明 AR 与总 DNMT 活性之间的负相关是影响 miR-375 启动子甲基化状态的机制之一,进而调节 miR-375 的表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/3868498/01dce232cbb4/OR-31-01-0034-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/3868498/c033071760c3/OR-31-01-0034-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/3868498/c9187846f31b/OR-31-01-0034-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/3868498/0ec903db3486/OR-31-01-0034-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/3868498/01dce232cbb4/OR-31-01-0034-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/3868498/c033071760c3/OR-31-01-0034-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/3868498/c9187846f31b/OR-31-01-0034-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/3868498/0ec903db3486/OR-31-01-0034-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e982/3868498/01dce232cbb4/OR-31-01-0034-g04.jpg

相似文献

1
Androgen receptor is negatively correlated with the methylation-mediated transcriptional repression of miR-375 in human prostate cancer cells.雄激素受体与 miR-375 的甲基化介导的转录抑制在人前列腺癌细胞中呈负相关。
Oncol Rep. 2014 Jan;31(1):34-40. doi: 10.3892/or.2013.2810. Epub 2013 Oct 24.
2
Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.用 5-氮杂-2'-脱氧胞苷(5-AZA)靶向前列腺干/祖细胞中雄激素受体(AR)启动子的独特甲基化模式可抑制前列腺肿瘤发生。
J Biol Chem. 2012 Nov 16;287(47):39954-66. doi: 10.1074/jbc.M112.395574. Epub 2012 Sep 25.
3
Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene.在前列腺癌细胞模型中,向转移性阶段的进展与雄激素受体基因的甲基化和胰岛素样生长因子-I 受体基因的转录抑制有关。
Exp Cell Res. 2010 May 15;316(9):1479-88. doi: 10.1016/j.yexcr.2010.03.007. Epub 2010 Mar 23.
4
Demethylation of the miR-146a promoter by 5-Aza-2'-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer.5-氮杂-2'-脱氧胞苷使miR-146a启动子去甲基化与去势抵抗性前列腺癌的进展延迟相关。
BMC Cancer. 2014 May 2;14:308. doi: 10.1186/1471-2407-14-308.
5
Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth.组蛋白抑制调节 G 蛋白信号 2 促进雄激素非依赖性前列腺癌细胞生长。
Int J Cancer. 2012 Apr 1;130(7):1521-31. doi: 10.1002/ijc.26138. Epub 2011 Jun 9.
6
Epigenetic regulation of androgen receptor gene expression in human prostate cancers.人类前列腺癌中雄激素受体基因表达的表观遗传调控
Lab Invest. 2000 Dec;80(12):1789-96. doi: 10.1038/labinvest.3780190.
7
Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer.PMEPA1基因的甲基化,前列腺癌中雄激素受体的负调节因子
Epigenetics. 2014 Jun;9(6):918-27. doi: 10.4161/epi.28710. Epub 2014 Apr 2.
8
Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.雄激素受体对前列腺癌细胞中抑癌miR-124的调控与甲基化作用
PLoS One. 2015 Apr 10;10(4):e0116197. doi: 10.1371/journal.pone.0116197. eCollection 2015.
9
Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians.miR-34b的差异表达与雄激素受体途径调节非裔美国人和高加索人前列腺癌侵袭性的差异。
Oncotarget. 2017 Jan 31;8(5):8356-8368. doi: 10.18632/oncotarget.14198.
10
MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.miRNA-27a-5p 通过启动子甲基化和 MYC 信号通路在前列腺癌发生中的调控作用。
Cell Death Dis. 2018 Feb 7;9(2):167. doi: 10.1038/s41419-017-0241-y.

引用本文的文献

1
Reciprocal regulation between DNMT3A/3B and microRNAs miRs-299-3p/-30e is a causal factor for the downregulation of microRNAs targeting androgen receptor in prostate cancer.DNMT3A/3B与微小RNA miR-299-3p/-30e之间的相互调控是前列腺癌中靶向雄激素受体的微小RNA下调的一个因果因素。
Heliyon. 2025 Jan 23;11(3):e41948. doi: 10.1016/j.heliyon.2025.e41948. eCollection 2025 Feb 15.
2
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer.雄激素受体的强效刺激会引发前列腺癌中的病毒模拟反应。
Cancer Res Commun. 2022 Jul 25;2(7):706-724. doi: 10.1158/2767-9764.CRC-21-0139. eCollection 2022 Jul.
3

本文引用的文献

1
Roles of microRNAs during prostatic tumorigenesis and tumor progression.微小 RNA 在前列腺肿瘤发生和肿瘤进展中的作用。
Oncogene. 2014 Jan 9;33(2):135-47. doi: 10.1038/onc.2013.54. Epub 2013 Mar 4.
2
Aberrant DNA methylation and prostate cancer.异常的 DNA 甲基化与前列腺癌。
Curr Genomics. 2011 Nov;12(7):486-505. doi: 10.2174/138920211797904061.
3
DNA methylation silences miR-132 in prostate cancer.DNA 甲基化使前列腺癌中的 miR-132 沉默。
TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer.
TRIM59受雄激素受体抑制,并在前列腺癌中发挥促进谱系可塑性和治疗诱导的神经内分泌分化的作用。
Oncogene. 2023 Feb;42(8):559-571. doi: 10.1038/s41388-022-02498-1. Epub 2022 Dec 21.
4
MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis.MicroRNA-375 是通过 PTPN4/STAT3 轴治疗去势抵抗性前列腺癌的治疗靶点。
Exp Mol Med. 2022 Aug;54(8):1290-1305. doi: 10.1038/s12276-022-00837-6. Epub 2022 Aug 30.
5
Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs.非编码RNA对前列腺癌神经内分泌样分化的调控
Noncoding RNA. 2021 Dec 2;7(4):75. doi: 10.3390/ncrna7040075.
6
Chidamide and Radiotherapy Synergistically Induce Cell Apoptosis and Suppress Tumor Growth and Cancer Stemness by Regulating the MiR-375-EIF4G3 Axis in Lung Squamous Cell Carcinomas.西达本胺与放疗协同诱导肺鳞状细胞癌细胞凋亡,通过调控miR-375-EIF4G3轴抑制肿瘤生长和癌症干性。
J Oncol. 2021 Jun 11;2021:4936207. doi: 10.1155/2021/4936207. eCollection 2021.
7
Androgen-induced epigenetic modulations in the ovary.雄激素诱导的卵巢表观遗传调控。
J Endocrinol. 2021 Jun;249(3):R53-R64. doi: 10.1530/JOE-20-0578.
8
Coordinated AR and microRNA regulation in prostate cancer.前列腺癌中雄激素受体(AR)与微小RNA的协同调控
Asian J Urol. 2020 Jul;7(3):233-250. doi: 10.1016/j.ajur.2020.06.003. Epub 2020 Jun 19.
9
MicroRNAs as Guardians of the Prostate: Those Who Stand before Cancer. What Do We Really Know about the Role of microRNAs in Prostate Biology?微小 RNA 作为前列腺的守护者:癌症面前的卫士。我们对微小 RNA 在前列腺生物学中的作用究竟了解多少?
Int J Mol Sci. 2020 Jul 7;21(13):4796. doi: 10.3390/ijms21134796.
10
Androgen-Regulated microRNAs (AndroMiRs) as Novel Players in Adipogenesis.雄激素调节的 microRNAs(AndroMiRs)作为脂肪生成中的新角色。
Int J Mol Sci. 2019 Nov 16;20(22):5767. doi: 10.3390/ijms20225767.
Oncogene. 2013 Jan 3;32(1):127-34. doi: 10.1038/onc.2012.14. Epub 2012 Feb 6.
4
miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1.miR-375 在鳞状宫颈癌中下调,通过靶向转录因子 SP1 抑制细胞迁移和侵袭。
Am J Pathol. 2011 Nov;179(5):2580-8. doi: 10.1016/j.ajpath.2011.07.037. Epub 2011 Sep 21.
5
MicroRNA-375 and MicroRNA-221: Potential Noncoding RNAs Associated with Antiproliferative Activity of Benzyl Isothiocyanate in Pancreatic Cancer.微小RNA-375和微小RNA-221:与异硫氰酸苄酯在胰腺癌中的抗增殖活性相关的潜在非编码RNA
Genes Cancer. 2011 Feb;2(2):108-19. doi: 10.1177/1947601911409212.
6
Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).抑瘤 microRNA-375 调控头颈部鳞状细胞癌(HNSCC)中的癌基因 AEG-1/MTDH。
J Hum Genet. 2011 Aug;56(8):595-601. doi: 10.1038/jhg.2011.66. Epub 2011 Jul 14.
7
A new trick of an old molecule: androgen receptor splice variants taking the stage?!旧分子的新把戏:雄激素受体剪接变体登上舞台?!
Int J Biol Sci. 2011;7(6):815-22. doi: 10.7150/ijbs.7.815. Epub 2011 Jul 6.
8
Epigenetic regulation of microRNA-375 and its role in melanoma development in humans.miRNA-375 的表观遗传调控及其在人类黑色素瘤发生中的作用。
FEBS Lett. 2011 Aug 4;585(15):2467-76. doi: 10.1016/j.febslet.2011.06.025. Epub 2011 Jun 26.
9
Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.食管鳞状细胞癌患者血浆中的循环 microRNAs。
Br J Cancer. 2011 Jun 28;105(1):104-11. doi: 10.1038/bjc.2011.198. Epub 2011 Jun 14.
10
Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.miRNA-375 下调前列腺癌中的 Sec23A 蛋白。
Mol Cancer Res. 2011 Jun;9(6):791-800. doi: 10.1158/1541-7786.MCR-10-0573. Epub 2011 May 18.